111 related articles for article (PubMed ID: 8195452)
1. Clozapine and metabolites: concentrations in serum and clinical findings during treatment of chronically psychotic patients.
Centorrino F; Baldessarini RJ; Kando JC; Frankenburg FR; Volpicelli SA; Flood JG
J Clin Psychopharmacol; 1994 Apr; 14(2):119-25. PubMed ID: 8195452
[TBL] [Abstract][Full Text] [Related]
2. Tissue concentrations of clozapine and its metabolites in the rat.
Baldessarini RJ; Centorrino F; Flood JG; Volpicelli SA; Huston-Lyons D; Cohen BM
Neuropsychopharmacology; 1993 Sep; 9(2):117-24. PubMed ID: 8216694
[TBL] [Abstract][Full Text] [Related]
3. Serum concentrations of clozapine and its major metabolites: effects of cotreatment with fluoxetine or valproate.
Centorrino F; Baldessarini RJ; Kando J; Frankenburg FR; Volpicelli SA; Puopolo PR; Flood JG
Am J Psychiatry; 1994 Jan; 151(1):123-5. PubMed ID: 8267110
[TBL] [Abstract][Full Text] [Related]
4. Serum concentrations of clozapine and norclozapine in the prediction of relapse of patients with schizophrenia.
Xiang YQ; Zhang ZJ; Weng YZ; Zhai YM; Li WB; Cai ZJ; Tan QR; Wang CY
Schizophr Res; 2006 Apr; 83(2-3):201-10. PubMed ID: 16524698
[TBL] [Abstract][Full Text] [Related]
5. Clozapine-induced electroencephalogram changes as a function of clozapine serum levels.
Freudenreich O; Weiner RD; McEvoy JP
Biol Psychiatry; 1997 Jul; 42(2):132-7. PubMed ID: 9209730
[TBL] [Abstract][Full Text] [Related]
6. Concurrent use of clozapine and valproate in affective and psychotic disorders.
Kando JC; Tohen M; Castillo J; Centorrino F
J Clin Psychiatry; 1994 Jun; 55(6):255-7. PubMed ID: 8071281
[TBL] [Abstract][Full Text] [Related]
7. NTP Toxicology and Carcinogenesis Studies of 4,4'-Thiobis(6- t -butyl- m -cresol) (CAS No. 96-69-5) in F344/N Rats and B6C3F1 Mice (Feed Studies).
National Toxicology Program
Natl Toxicol Program Tech Rep Ser; 1994 Dec; 435():1-288. PubMed ID: 12595928
[TBL] [Abstract][Full Text] [Related]
8. Clozapine pharmacokinetics in children and adolescents with childhood-onset schizophrenia.
Frazier JA; Cohen LG; Jacobsen L; Grothe D; Flood J; Baldessarini RJ; Piscitelli S; Kim GS; Rapoport JL
J Clin Psychopharmacol; 2003 Feb; 23(1):87-91. PubMed ID: 12544379
[TBL] [Abstract][Full Text] [Related]
9. Using antipsychotic agents in older patients.
Alexopoulos GS; Streim J; Carpenter D; Docherty JP;
J Clin Psychiatry; 2004; 65 Suppl 2():5-99; discussion 100-102; quiz 103-4. PubMed ID: 14994733
[TBL] [Abstract][Full Text] [Related]
10. Leptin concentrations are increased in subjects treated with clozapine or conventional antipsychotics.
Hägg S; Söderberg S; Ahrén B; Olsson T; Mjörndal T
J Clin Psychiatry; 2001 Nov; 62(11):843-8. PubMed ID: 11775042
[TBL] [Abstract][Full Text] [Related]
11. Review and management of clozapine side effects.
Miller DD
J Clin Psychiatry; 2000; 61 Suppl 8():14-7; discussion 18-9. PubMed ID: 10811238
[TBL] [Abstract][Full Text] [Related]
12. [Antipsychotic efficacy in relation to plasma levels of clozapine (author's transl)].
Ackenheil M; Bräu H; Burkhart A; Franke A; Pacha W
Arzneimittelforschung; 1976; 26(6):1156-8. PubMed ID: 989406
[TBL] [Abstract][Full Text] [Related]
13. Predictors of clinical outcome in schizophrenic patients responding to clozapine.
Mauri MC; Volonteri LS; Dell'Osso B; Regispani F; Papa P; Baldi M; Bareggi SR
J Clin Psychopharmacol; 2003 Dec; 23(6):660-4. PubMed ID: 14624196
[TBL] [Abstract][Full Text] [Related]
14. Clozapine, norclozapine plasma levels, their sum and ratio in 50 psychotic patients: influence of patient-related variables.
Palego L; Biondi L; Giannaccini G; Sarno N; Elmi S; Ciapparelli A; Cassano GB; Lucacchini A; Martini C; Dell'Osso L
Prog Neuropsychopharmacol Biol Psychiatry; 2002 Apr; 26(3):473-80. PubMed ID: 11999897
[TBL] [Abstract][Full Text] [Related]
15. [Clozapine in the treatment of adverse psychiatric manifestations of long-term therapy with levodopa].
Svetel MV; Sternić NM; Filipović SR; Vojvodić NM; Kostić VS
Srp Arh Celok Lek; 1997; 125(7-8):203-6. PubMed ID: 9304232
[TBL] [Abstract][Full Text] [Related]
16. [Neuroleptic malignant syndrome and atypical antipsychotics: a brief review].
Khaldi S; Kornreich C; Choubani Z; Gourevitch R
Encephale; 2008 Dec; 34(6):618-24. PubMed ID: 19081460
[TBL] [Abstract][Full Text] [Related]
17. Safety evaluation of the concomitant use of clozapine and benzodiazepines: a retrospective, cross-sectional chart review.
Bitter R; Demler TL; Opler L
J Psychiatr Pract; 2008 Sep; 14(5):265-70. PubMed ID: 18832957
[TBL] [Abstract][Full Text] [Related]
18. Relation of leukocyte counts during clozapine treatment to serum concentrations of clozapine and metabolites.
Centorrino F; Baldessarini RJ; Flood JG; Kando JC; Frankenburg FR
Am J Psychiatry; 1995 Apr; 152(4):610-2. PubMed ID: 7694912
[TBL] [Abstract][Full Text] [Related]
19. Effect of Valproate and Antidepressant Drugs on Clozapine Metabolism in Patients With Psychotic Mood Disorders.
Marazziti D; Palego L; Betti L; Giannaccini G; Massimetti E; Baroni S; Ciapparelli A; Lucacchini A; Mucci F; DellʼOsso L
Ther Drug Monit; 2018 Aug; 40(4):443-451. PubMed ID: 29601407
[TBL] [Abstract][Full Text] [Related]
20. Determination of pharmacokinetic properties of clozapine and norclozapine in Korean schizophrenia patients.
Lee ST; Ryu S; Nam HJ; Lee SY; Hong KS
Int Clin Psychopharmacol; 2009 May; 24(3):139-44. PubMed ID: 19194306
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
